ArticleFrontiers in cardiovascular medicine2025
Case Report: Acute methicillin-sensitive
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Bacterial pericarditis is rare in the antibiotic era but remains potentially fatal due to rapid progression and high mortality. Herein, we report an unusual case of methicillin-sensitive Patient concerns and clinical findings: A 47-year-old female patient with a history of presumptive ischemic cardiomyopathy, uncontrolled DM (a glycated hemoglobin level of 14.2%), and treated pulmonary tuberculosis (TB) presented with pleuritic chest tightness, fever, and dyspnea. Examinations and investigations revealed a moderate-to-large pericardial effusion, ST-segment elevation on an electrocardiogram, and high inflammatory markers. Imaging showed a pericardial effusion, raising suspicion for bacterial pericarditis. Pleural tap of an adjacent pleural effusion nearby was however transudative. Diagnosis interventions and outcomes: Pericardiocentesis was not feasible due to the loculated pericardial effusion and absence of a safe window; however, Conclusion: This case emphasizes the need to consider bacterial etiologies, including MSSA, when evaluating pericarditis in immunocompromised patients, especially those with DM or prior TB. Multimodal imaging, molecular diagnostics, and early surgical consultation are important in cases where pericardiocentesis is not feasible. Invasive diagnostic strategies may be critical for achieving a microbiological diagnosis and ensuring timely source control. Multidisciplinary collaboration is essential when managing complex pericardial infections to optimize diagnostic certainty and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.